# AGGRENOX
> **NDA020884** · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 1999-11-22
## Drug
- **FDA Application Number:** NDA020884
- **Application type:** New Drug Application
- **Brand name:** AGGRENOX
- **Generic name:** Aspirin
- **Active ingredients:** ASPIRIN; DIPYRIDAMOLE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** BOEHRINGER INGELHEIM
- **First approval:** 1999-11-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020884)
---
*AI Analytics · CC0 1.0*